Markus Matilainen
PhD
Turku PET Centre manmat@utu.fi +358 29 450 4739 +358 50 472 8469 Itäinen Pitkäkatu 4 Turku |
Statistics; Biostatistics; Blind Source Separation
5 of 8
- Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study (2021)
- Multiple Sclerosis and Related Disorders
- High serum neurofilament associates with diffuse white matter damage in MS (2021)
- Neurology, Neuroimmunology and Neuroinflammation
- Implant survival of 2,723 vitamin E-infused highly crosslinked polyethylene liners in total hip arthroplasty: data from the Finnish Arthroplasty Register (2021)
- Acta Orthopaedica
- Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI (2021)
- Multiple Sclerosis and Related Disorders
- Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis (2020)
- Brain
- Effect of Dopaminergic Medication on Adenosine 2A Receptor Availability in Patients with Parkinson’s Disease (2020) Imran Waggan, Jouni Tuisku, Markus Matilainen, Semi Helin, Riitta Parkkola, Eero Rissanen, Juha Rinne, Laura Airas,
- Frequency and etiology of acute transverse myelitis in Southern Finland (2020)
- Multiple Sclerosis and Related Disorders
- Implant Survival of 6,080 Tritanium Cups in Primary Total Hip Arthroplasty Data from the Finnish Arthroplasty Register from 2009 to 2017 (2020)
- Journal of Bone and Joint Surgery, American Volume
- Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging (2020)
- Neurology, Neuroimmunology and NeuroinflammationMultiple Sclerosis and Related Disorders
- Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland (2020)
UTU Research Portal